SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects – correspondence

por Channabasappa, Nikhil K., Niranjan, Ankush K., Emran, Talha B.
Publicado 2023

Omicron: a challenge to hybrid immunity – correspondence

por Niranjan, Ankush K., Patel, Shailesh K., Emran, Talha B.
Publicado 2023

Mpox and the need for improved diagnostics – correspondence

por Patel, Shailesh K., Rana, Jigyasa, Agrawal, Aditya, Channabasappa, Nikhil K., Niranjan, Ankush K., Emran, Talha B.
Publicado 2023

Spillover of viruses and global concern: is simian haemorrhagic fever virus next in queue? – correspondence

por Patel, Shailesh K., Niranjan, Ankush K., Channabasappa, Nikhil K., Rana, Jigyasa, Agrawal, Aditya, Emran, Talha B.
Publicado 2023

Resurgence of cholera in the COVID-19 era: a global health concern

por Niranjan, Ankush K., Patel, Shailesh K., Channabasappa, Nikhil K., Rana, Jigyasa, Agrawal, Aditya, Kumar, Rakesh, Pandey, Megha K., Tiwari, Sita P., Singh, Devendra R.
Publicado 2023

Vitamin D in therapy and management: armor against COVID-19 – correspondence

por Channabasappa, Nikhil K., Patel, Shailesh K., Singh, Devendra R., Niranjan, Ankush K., Rana, Jigyasa, Agrawal, Aditya, Govil, Kumar, Pandey, Megha K., Tiwari, Sita P.
Publicado 2023

Mpox vaccination in global perspective: priorities and challenges

por Rana, Jigyasa, Patel, Shailesh Kumar, Agrawal, Aditya, Channabasappa, Nikhil K., Niranjan, Ankush K., Chandra Das, Bhabesh, Pandey, Megha K., Tiwari, Sita Prasad, Gaihre, Milan
Publicado 2023